BUY Supriya Lifescience Limited — Choice Broking
byChoice BrokingHorizon: NA (inferred 1–3 months)6 Jul 2026via Economic Times New Stock Recos
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·6 Sept · today
Supriya Lifescience announces Q1 FY27 results with revenue at ₹1,897.5 million
NewsGoogle News·13 Aug · 3w ago
Supriya Lifescience: Q1 FY27 Profit Soars 196% to ₹240 Crore
NewsGoogle News·13 Aug · 3w ago
Supriya Lifescience: Q1 FY27 Revenue Jumps 144% to ₹1,897 Cr
NewsGoogle News·13 Aug · 3w ago
Nothing found in this tip’s window yet.
Past month's volume 1.5× the prior month's average
Technicals · volume·4 Sept · 2d ago
Supriya Lifescience के शेयर में गिरावट! रेवेन्यू बढ़ा पर प्रॉफिट घटा, जानें वजह
NewsGoogle News·18 Aug · 3w ago
Supriya Lifescience Share: આવક વધી પણ નફો ઘટ્યો, રોકાણકારો માટે શું છે સારા સમાચાર?
NewsGoogle News·18 Aug · 3w ago
సుప్రియా లైఫ్సైన్స్: రెవెన్యూలో దూకుడు, కానీ లాభాల్లో తగ్గుదల! కారణమేంటి?
NewsGoogle News·18 Aug · 3w ago
Supriya Lifescience Q1 Net Profit Drops To 240M Rupees From 348M YoY
NewsGoogle News·13 Aug · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.